Literature DB >> 19352650

Comparison of engineered Saccharomyces cerevisiae and engineered Escherichia coli for the production of an optically pure keto alcohol.

Nádia Skorupa Parachin1, Magnus Carlquist, Marie F Gorwa-Grauslund.   

Abstract

In this study, the production of enantiomerically pure (1R,4S,6S)-6-hydroxy-bicyclo[2.2.2]octane-2-one ((-)-2) through stereoselective bioreduction was used as a model reaction for the comparison of engineered Saccharomyces cerevisiae and engineered Escherichia coli as biocatalysts. For both microorganisms, over-expression of the gene encoding the NADPH-dependent aldo-keto reductase YPR1 resulted in high purity of the keto alcohol (-)-2 (>99% ee, 97-98% de). E. coli had three times higher initial reduction rate but S. cerevisiae continued the reduction reaction for a longer time period, thus reaching a higher conversion of the substrate (95%). S. cerevisiae was also more robust than E. coli, as demonstrated by higher viability during bioreduction. It was also investigated whether the NADPH regeneration rate was sufficient to supply the over-expressed reductase with NADPH. Five strains of each microorganism with varied carbon flux through the NADPH regenerating pentose phosphate pathway were genetically constructed and compared. S. cerevisiae required an increased NADPH regeneration rate to supply YPR1 with co-enzyme while the native NADPH regeneration rate was sufficient for E. coli.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352650     DOI: 10.1007/s00253-009-1964-1

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  4 in total

1.  Engineered baker's yeast as whole-cell biocatalyst for one-pot stereo-selective conversion of amines to alcohols.

Authors:  Nora Weber; Marie Gorwa-Grauslund; Magnus Carlquist
Journal:  Microb Cell Fact       Date:  2014-08-12       Impact factor: 5.328

2.  Increased availability of NADH in metabolically engineered baker's yeast improves transaminase-oxidoreductase coupled asymmetric whole-cell bioconversion.

Authors:  Jan Dines Knudsen; Cecilia Hägglöf; Nora Weber; Magnus Carlquist
Journal:  Microb Cell Fact       Date:  2016-02-15       Impact factor: 5.328

3.  Exploring the potential of the glycerol-3-phosphate dehydrogenase 2 (GPD2) promoter for recombinant gene expression in Saccharomyces cerevisiae.

Authors:  Jan Dines Knudsen; Ted Johanson; Anna Eliasson Lantz; Magnus Carlquist
Journal:  Biotechnol Rep (Amst)       Date:  2015-06-15

4.  Exploiting cell metabolism for biocatalytic whole-cell transamination by recombinant Saccharomyces cerevisiae.

Authors:  Nora Weber; Marie Gorwa-Grauslund; Magnus Carlquist
Journal:  Appl Microbiol Biotechnol       Date:  2014-02-21       Impact factor: 4.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.